Nivolumab

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
Bin Zhao, Hong Zhao, Jiaxin Zhao

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 101; DOI: 10.1186/s40425-018-0421-z
Safety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 study
Asim Amin, Elizabeth R Plimack, Marc S Ernstoff, Lionel D Lewis, Todd M Bauer, David F McDermott, Michael Carducci, Christian Kollmannsberger, Brian I Rini, Daniel Y C Heng, Jennifer Knox, Martin H Voss, Jennifer Spratlin, Elmer Berghorn, Lingfeng Yang, Hans J Hammers

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 109; DOI: 10.1186/s40425-018-0420-0
Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients
Sarabjot Pabla, Jeffrey M. Conroy, Mary K. Nesline, Sean T. Glenn, Antonios Papanicolau-Sengos, Blake Burgher, Jacob Hagen, Vincent Giamo, Jonathan Andreas, Felicia L. Lenzo, Wang Yirong, Grace K. Dy, Edwin Yau, Amy Early, Hongbin Chen, Wiam Bshara, Katherine G. Madden, Keisuke Shirai, Konstantin Dragnev, Laura J. Tafe, Daniele Marin, Jason Zhu, Jeff Clarke, Matthew Labriola, Shannon McCall, Tian Zhang, Matthew Zibelman, Pooja Ghatalia, Isabel Araujo-Fernandez, Arun Singavi, Ben George, Andrew Craig MacKinnon, Jonathan Thompson, Rajbir Singh, Robin Jacob, Lynn Dressler, Mark Steciuk, Oliver Binns, Deepa Kasuganti, Neel Shah, Marc Ernstoff, Kunle Odunsi, Razelle Kurzrock, Mark Gardner, Lorenzo Galluzzi, Carl Morrison

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 27; DOI: 10.1186/s40425-019-0506-3
Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer
Lorenza Landi, Federica D’Incà, Alain Gelibter, Rita Chiari, Francesco Grossi, Angelo Delmonte, Antonio Passaro, Diego Signorelli, Francesco Gelsomino, Domenico Galetta, Diana Giannarelli, Hector Soto Parra, Gabriele Minuti, Marcello Tiseo, Maria Rita Migliorino, Francesco Cognetti, Luca Toschi, Paolo Bidoli, Francovito Piantedosi, Luana Calabro’, Federico Cappuzzo

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 316; DOI: 10.1186/s40425-019-0793-8
Characterization of immune responses to anti-PD-1 mono and combination immunotherapy in hematopoietic humanized mice implanted with tumor xenografts
A. Capasso, J. Lang, T. M. Pitts, K. R. Jordan, C. H. Lieu, S. L. Davis, J. R. Diamond, S. Kopetz, J. Barbee, J. Peterson, B. M. Freed, B. W. Yacob, S. M. Bagby, W. A. Messersmith, J. E. Slansky, R. Pelanda, S. G. Eckhardt

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 37; DOI: 10.1186/s40425-019-0518-z
Immune checkpoint inhibitor related myasthenia gravis: single center experience and systematic review of the literature
Houssein Safa, Daniel H Johnson, Van Anh Trinh, Theresa E Rodgers, Heather Lin, Maria E Suarez-Almazor, Faisal Fa’ak, Chantal Saberian, Cassian Yee, Michael A Davies, Sudhakar Tummala, Karin Woodman, Noha Abdel-Wahab, Adi Diab

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 319; DOI: 10.1186/s40425-019-0774-y
Complete response of renal cell carcinoma vena cava tumor thrombus to neoadjuvant immunotherapy
Craig Labbate, Ken Hatogai, Ryan Werntz, Walter M. Stadler, Gary D. Steinberg, Scott Eggener, Randy F. Sweis

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 66; DOI: 10.1186/s40425-019-0546-8
Multiple nivolumab-induced CNS demyelination with spontaneous resolution in an asymptomatic metastatic melanoma patient
Vincent Pillonel, Vincent Dunet, Andreas F. Hottinger, Gregoire Berthod, Luis Schiappacasse, Solange Peters, Olivier Michielin, Veronica Aedo-Lopez

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 336; DOI: 10.1186/s40425-019-0818-3
Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series
Paul T. Finger, Anna C. Pavlick

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 83; DOI: 10.1186/s40425-019-0555-7
Incidence rates of immune-related adverse events and their correlation with response in advanced solid tumours treated with NIVO or NIVO+IPI: a systematic review and meta-analysis
Puyuan Xing, Fan Zhang, Guoqiang Wang, Yu Xu, Chengcheng Li, Shouzheng Wang, Yiying Guo, Shangli Cai, Yan Wang, Junling Li

Journal for ImmunoTherapy of Cancer Dec 2019, 7 (1) 341; DOI: 10.1186/s40425-019-0779-6

Main menu

Nivolumab

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Nivolumab

Pages